Skip to main content
About
Contact
Subscribe
e-Edition
Make Home Page
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
Facebook
Twitter
Toggle navigation
Site search
Search
Home
Contact Us
Advertise
Subscription Services
Promote Your Event
Submission Forms
News
Local News
National
World
Archives
Sports
Local Sports
National Sports
Business
Local Business
National Business
Technology
Markets & Stocks
Opinion
Columns
Editorials
Letters To The Editor
Polls
Thumbs
A & E
Local Entertainment
Art Scene
Music Scene
Theatre Scene
Book Reviews
Movie Reviews
TV Listings
Local Events
What To Do
Life
Health
Travel
Oddities
Community Directory
Community Service
Rescue Me
Other
Magazines
Fall Home Improvements
Women
Home & Realty
Outdoor Guide
Premier Home Style Tour 2024
Spring Home & Garden Show
Spring on the Road
Spring Wellness
Classifieds
Place Ad
Careers
Tenders
Weather
Obituaries
Parcel Pickup
2024 Readersâ Choice
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Business Exposures
Activism
Animal Testing
Artificial Intelligence
Boeing 737
Brexit
Cannabis
Censorship
Climate
Coal
COVID-19
Criminal
Death
Debt Markets
Derivatives
Diversity
Economy
Electric Vehicles
Electricity Generation
Ethanol
Financial
Firearms
Fossil Fuels
Glyphosate
Harassement
Immigration
Information Security
Intellectual Property
Interest Rates
Labor
Layoff
Lead
Legal
Palm Oil
Pension
Political
Product Safety
Regulatory
Religion
Securities Market
Supply Chain
Tariff
Textiles
US Equities
< Previous
1
2
3
4
5
6
7
8
9
...
99
100
Next >
APLT Deadline in 5 Days: Kessler Topaz Meltzer & Check, LLP Reminds Applied Therapeutics, Inc. (APLT) Investors of Filing Deadline in Class Action Lawsuit
Today 13:30 EST
Via
TheNewswire.com
Topics
Lawsuit
Exposures
Financial
Legal
Product Safety
Tickers
APLT
Why Is Blood Cancer Focused Moleculin Biotech Stock Trading More Than 400% On Thursday?
Today 13:19 EST
Via
Benzinga
Exposures
Product Safety
Tickers
MBRX
DEADLINE ALERT: Kaplan Fox Alerts Investors to a Securities Class Action Against Applied Therapeutics, Inc. (APLT) - Deadline is February 18, 2025
Today 9:00 EST
Via
NewMediaWire
Topics
Lawsuit
Exposures
Financial
Legal
Product Safety
Tickers
APLT
DEADLINE ALERT: Kaplan Fox Alerts Investors to a Securities Class Action Against Applied Therapeutics, Inc. (APLT) - Deadline is February 18, 2025
Today 9:00 EST
Via
TheNewswire.com
Topics
Lawsuit
Exposures
Financial
Legal
Product Safety
Tickers
APLT
GCDRI announces the provision of CE Marking and FDA certification services
February 10, 2025
Via
AB Newswire
Exposures
Product Safety
Tech Entrepreneur Transforms Personal Struggle into Revolutionary AI Platform Called Magai
Today 8:35 EST
Via
Press Release Distribution Service
Topics
Artificial Intelligence
Product Recall
Exposures
Artificial Intelligence
Legal
Product Safety
BioMedNewsBreaks – RenovoRx Inc. (NASDAQ: RNXT) Announces $12.1M Underwritten Public Offering
February 12, 2025
Via
Investor Brand Network
Exposures
Product Safety
Tickers
RNXT
SpringWorks Therapeutics Secures FDA Approval For Second Cancer Drug
February 12, 2025
Via
Benzinga
Exposures
Product Safety
Tickers
SWTX
Reports Reveal New York Magazine, Prohibitionists Collaborated to Create Series Against MDMA Therapy
February 12, 2025
Via
Investor Brand Network
Exposures
Product Safety
GLP-1 Alternatives: 2 Stocks Benefiting From Weight Loss Trends
February 12, 2025
Via
MarketBeat
Exposures
Product Safety
Tickers
HIMS
LFVN
LLY
NVO
Kaplan Fox & Kilsheimer LLP Alerts Investors to a Securities Class Action Against Applied Therapeutics, Inc. (APLT) - Deadline is February 18, 2025
February 12, 2025
Via
NewMediaWire
Topics
Lawsuit
Exposures
Financial
Legal
Product Safety
Tickers
APLT
Kaplan Fox & Kilsheimer LLP Alerts Investors to a Securities Class Action Against Applied Therapeutics, Inc. (APLT) - Deadline is February 18, 2025
February 12, 2025
Via
TheNewswire.com
Topics
Lawsuit
Exposures
Financial
Legal
Product Safety
Tickers
APLT
Trapped in addiction: Lebogang is finally free from one of South Africa’s dangerous drug
February 12, 2025
Via
Press Release Distribution Service
Topics
Product Recall
Exposures
Legal
Product Safety
Travere Therapeutics Sparks Retail Frenzy As Stock Hits Over 2-Year High On FDA Approval Plan For Kidney-Disease Drug
February 11, 2025
Via
Stocktwits
Exposures
Product Safety
Tickers
IWM
TVTX
VTI
XBI
APLT SHAREHOLDER ALERT: Applied Therapeutics Investors are Encouraged to Contact Kaplan Fox Before Lead Plaintiff Deadline on February 18, 2025
February 11, 2025
Via
NewMediaWire
Topics
Lawsuit
Exposures
Financial
Legal
Product Safety
Tickers
APLT
APLT SHAREHOLDER ALERT: Applied Therapeutics Investors are Encouraged to Contact Kaplan Fox Before Lead Plaintiff Deadline on February 18, 2025
February 11, 2025
Via
TheNewswire.com
Topics
Lawsuit
Exposures
Financial
Legal
Product Safety
Tickers
APLT
Travere Therapeutics Skyrockets After Reaching FDA Deal For Kidney Disease Drug
February 11, 2025
Via
Investor's Business Daily
Exposures
Product Safety
Tickers
TVTX
Nano Cap Lipella Pharmaceuticals Stock Jumps On Positive Trial Data In Patients With Sore Mouth Membranes
February 11, 2025
Via
Benzinga
Exposures
Product Safety
Tickers
LIPO
Biohaven Just Hurdled An FDA Setback — And Its Moving Lines
February 11, 2025
Via
Investor's Business Daily
Exposures
Product Safety
Tickers
BHVN
Artificial Intelligence (AI) Influence on Healthcare Market Expected to Generate Revenues of $610 Billion By 2034
February 11, 2025
Via
FinancialNewsMedia
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
Product Safety
Tickers
AVAI
BBAI
SOUN
TALK
Avant Technologies and Ainnova Advance Toward FDA Clinical Trial with Selection of Top CRO
February 11, 2025
Via
FinancialNewsMedia
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
Product Safety
Tickers
AVAI
Biodexa Stock Surges On FDA's Fast-Track Tag For Treatment Of Cancer-Causing Condition: Retail Confidence Peaks
February 10, 2025
Via
Stocktwits
Exposures
Product Safety
Tickers
BDRX
What's Going On With Bristol Myers Squibb Stock On Monday?
February 10, 2025
Via
Benzinga
Exposures
Product Safety
Tickers
BMY
APLT INVESTOR ALERT: Investors of Applied Therapeutics are Encouraged to Contact Kaplan Fox Before Lead Plaintiff Deadline
February 10, 2025
Via
NewMediaWire
Topics
Lawsuit
Exposures
Financial
Legal
Product Safety
Tickers
APLT
APLT INVESTOR ALERT: Investors of Applied Therapeutics are Encouraged to Contact Kaplan Fox Before Lead Plaintiff Deadline
February 10, 2025
Via
TheNewswire.com
Topics
Lawsuit
Exposures
Financial
Legal
Product Safety
Tickers
APLT
These 5 Health Care Stocks Saw The Sharpest Retail Interest Jump Last Week
February 10, 2025
Via
Stocktwits
Exposures
Product Safety
Tickers
GHRS
IVVD
LIPO
MBX
APLT Investor Alert: A Securities Fraud Class Action Lawsuit Has Been Filed Against Applied Therapeutics, Inc. (APLT)
February 09, 2025
Via
TheNewswire.com
Topics
Fraud
Lawsuit
Exposures
Financial
Legal
Product Safety
Tickers
APLT
APLT Investor Alert: A Securities Fraud Class Action Lawsuit Has Been Filed Against Applied Therapeutics, Inc. (APLT)
February 09, 2025
Via
NewMediaWire
Topics
Fraud
Lawsuit
Exposures
Financial
Legal
Product Safety
Tickers
APLT
'I Need $30 Billion By Tonight' – Jamie Dimon Recalls The 'Breathless' Moment He Pulled Off 6 Months Of Work In 2 Days During 2008 Crisis
February 08, 2025
Via
Benzinga
Topics
Product Recall
Exposures
Legal
Product Safety
Tickers
JPM
SHAREHOLDER ALERT: Kaplan Fox & Kilsheimer LLP Alerts Investors to a Securities Class Action Against Applied Therapeutics, Inc. (APLT) - Deadline is February 18, 2025
February 08, 2025
Via
TheNewswire.com
Topics
Lawsuit
Exposures
Financial
Legal
Product Safety
Tickers
APLT
< Previous
1
2
3
4
5
6
7
8
9
...
99
100
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.